2004
DOI: 10.1038/sj.bjc.6602170
|View full text |Cite
|
Sign up to set email alerts
|

Social and geographical factors influencing the delay in treatment for colorectal cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

3
4
0

Year Published

2007
2007
2018
2018

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 7 publications
(7 citation statements)
references
References 2 publications
3
4
0
Order By: Relevance
“…Other barriers to obtaining a timely diagnosis included faulty initial diagnoses, structural barriers such as physicians delaying a referral for further testing or to a specialist, and patients who failed to follow through with physician recommendation. These findings coincide with those of other studies [1216]. …”
Section: Discussionsupporting
confidence: 93%
See 1 more Smart Citation
“…Other barriers to obtaining a timely diagnosis included faulty initial diagnoses, structural barriers such as physicians delaying a referral for further testing or to a specialist, and patients who failed to follow through with physician recommendation. These findings coincide with those of other studies [1216]. …”
Section: Discussionsupporting
confidence: 93%
“…While most studies have examined breast cancer or a mix of cancers, several have been specific to CRC. CRC DD in a French sample was not associated with geographic or demographic factors such as gender, marital status, or type of physician first consulted [12]. In Denmark, lack of knowledge about the significance of bowel symptoms was a main component of CRC patient delay [13].…”
Section: Introductionmentioning
confidence: 99%
“…Women and patients with lower household income tend to have treatment delays, which was consistent with the observations in patients with colorectal cancer that women 28 and patients on welfare 29 had a longer treatment delay. Finally, although some studies indicate smoking status is a significant predictor of diagnostic delay for head and neck cancer, 30,31 our data point to no effect of cigarette smoking on the treatment delay.…”
Section: Discussionsupporting
confidence: 86%
“…To provide an indication of trends in practices across time in France, we collated information from four comparable studies performed between 1900 and 2004 [4,14,36,39]. We note that the general trend for chemotherapy use in stage II patients did not change between 1990-1999 (21.8%) [4] to 2000 (20.4%) [14] and 2003/2004 (20.6%) in the present study.…”
Section: Discussionmentioning
confidence: 80%